NSAIDs to help form new cancer treatments?

1 June 2012

Further evidence has been given that non-steroidal anti-inflammatory drugs (NSAIDs) can help in the battle against various forms of cancer.

Earlier this week, Sigrun Alba Johannesdottir, of the Aarhus University Hospital in Denmark, led a team of researchers in a study which found that the medication can significantly reduce the effects of skin cancer from developing.

Now, scientists from the Universities of Bristol and Sheffield have claimed that NSAIDs can have more widespread benefits.

The researchers studied translucent zebrafish larvae as part of their investigation, in which they found that drugs like aspirin can starve cancer cells of white blood cells that act as the disease's early-growth support.

Paul Martin, professor of Cell Biology at the University of Bristol's Schools of Biochemistry and Physiology and Pharmacology, noted: "These findings are important as they help explain the underlying cellular processes at work which could be used to develop potential new therapies for eliminating early-stage cancer in humans."

Posted by Jeanette Royston

Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.

Find a treatment, test or scan available at:


Find a consultant

Use one or more of the options below to search for a consultant and link through to view their Spire profile.


Let us help you

fill out this form and we will get back to you:

Please select a hospital

We can call you

Please enter your details below and we will call you back.

What is the aim of your enquiry?

Please select a hospital

If we are unable to reach you by phone, please include your email address so that we can get in touch...



© Spire Healthcare Group plc (2016)